Global Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook
Global viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
Global viral vector and plasmid dna manufacturing market highlights
- The global viral vector and plasmid dna manufacturing market generated a revenue of USD 5,333.8 million in 2023 and is expected to reach USD 19,501.9 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 20.3% by 2030.
- In terms of segment, adeno-associated virus (aav) accounted for a revenue of USD 1,066.9 million in 2023.
- Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 5,333.8 million |
| Market revenue in 2030 | USD 19,501.9 million |
| Growth rate | 20.3% (CAGR from 2023 to 2030) |
| Largest segment | Adeno-associated virus (aav) |
| Fastest growing segment | Adeno-associated virus (AAV) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids |
Other key industry trends
- In terms of revenue, the North America accounted for 49.0% of the global viral vector and plasmid dna manufacturing market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 14.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Vector And Plasmid DNA Manufacturing Market Scope
Viral Vector And Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global viral vector and plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) was the largest segment with a revenue share of 20% in 2023. Horizon Databook has segmented the Global viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Viral Vector And Plasmid DNA Manufacturing Vector Type Outlook (Revenue, USD Million, 2018-2030)
- Adeno-associated virus (AAV)
- Lentivirus
- Adenovirus
- Retrovirus
- Plasmids
- Others
- Global Viral Vector And Plasmid DNA Manufacturing Workflow Outlook (Revenue, USD Million, 2018-2030)
- Upstream Processing
- Vector Amplification & Expansion
- Vector Recovery/Harvesting
- Downstream Processing
- Purification
- Fill-finish
- Upstream Processing
- Global Viral Vector And Plasmid DNA Manufacturing Application Outlook (Revenue, USD Million, 2018-2030)
- Antisense & RNAi
- Gene Therapy
- Cell Therapy
- Vaccinology
- Research Applications
- Global Viral Vector And Plasmid DNA Manufacturing End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
- Global Viral Vector And Plasmid DNA Manufacturing Disease Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
Reasons to subscribe to Global viral vector and plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global viral vector and plasmid dna manufacturing market databook
-
Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global viral vector and plasmid dna manufacturing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Viral vector and plasmid dna manufacturing market size, 2023 (US$M)
Global viral vector and plasmid dna manufacturing market share, by vector type, 2023 & 2030 (%, US$M)
Viral vector and plasmid dna manufacturing market: Opportunity assessment by country
Global viral vector and plasmid dna manufacturing market, by region, 2023 (US$M)
| Vector Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1,042.8 | 1,173.4 | 1,449.6 | 1,736.5 | 2,134.1 | 2,611.5 | 3,169.9 | 3,814.5 | 4,585.3 | 5,503.1 | 6,609.2 | 7,928.8 | 9,531.5 | 20.3% |
| Europe | 589.4 | 668.7 | 739.6 | 884.0 | 1,083.9 | 1,323.4 | 1,602.8 | 1,924.3 | 2,307.9 | 2,763.5 | 3,311.3 | 3,963.4 | 4,753.6 | 20.0% |
| Asia Pacific | 342.1 | 394.8 | 547.3 | 665.1 | 829.0 | 1,028.8 | 1,266.0 | 1,544.3 | 1,881.4 | 2,288.1 | 2,784.2 | 3,383.6 | 4,119.8 | 21.9% |
| Latin America | 148.4 | 163.7 | 147.9 | 175.0 | 212.4 | 256.7 | 307.6 | 365.4 | 433.5 | 513.3 | 608.2 | 719.7 | 853.2 | 18.7% |
| MEA | 60.0 | 64.7 | 74.0 | 84.2 | 98.0 | 113.4 | 129.5 | 146.2 | 164.0 | 182.8 | 202.7 | 223.0 | 243.8 | 11.6% |
| Overall | 2,182.8 | 2,465.4 | 2,958.4 | 3,544.9 | 4,357.5 | 5,333.8 | 6,475.7 | 7,794.7 | 9,372.1 | 11,250.8 | 13,515.7 | 16,218.5 | 19,501.9 | 20.4% |
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
